Keyphrases
Liver Cancer
100%
Proteogenomics
100%
Precision Oncology
100%
Cancer Organoids
100%
Organoid Biobank
42%
Proteomic Analysis
28%
Drug Response
28%
Organoids
28%
Tumor
14%
Patient-derived Xenograft
14%
Cancer Types
14%
Response Pattern
14%
Patient-derived
14%
Histopathological Features
14%
Organoid Models
14%
High-throughput Screening
14%
Precision Medicine
14%
Metabolic
14%
Genomic Analysis
14%
Biomedical Research
14%
Molecular Characteristics
14%
Transcriptome Analysis
14%
MTOR Inhibitor
14%
Cancer Biology
14%
Patient Prognosis
14%
Temsirolimus
14%
Synergistic Inhibition
14%
Molecular Features
14%
Integrative Analysis
14%
Drug Combination
14%
Epigenetic Analysis
14%
Personalized Patient Treatment
14%
Potential Drugs
14%
Biomarkers of Response
14%
Distinct Responses
14%
Web Portal
14%
Lenvatinib
14%
Multi-targeted Tyrosine Kinase Inhibitors
14%
Response Features
14%
Proteomic Signature
14%
Multi-omics Profiling
14%
Functional Precision Medicine
14%
Medicine and Dentistry
Liver Cancer
100%
Oncology
100%
Organoid
100%
Proteogenomics
100%
Drug Response
28%
Biological Marker
14%
Neoplasm
14%
Cancer Types
14%
Proteomics
14%
Personalized Medicine
14%
Xenograft
14%
Transcriptomics
14%
Mammalian Target of Rapamycin Inhibitor
14%
Cancer Pathobiology
14%
Biomedical Research
14%
Temsirolimus
14%
Combination Drug
14%
Tyrosine-Kinase Inhibitor
14%
High Throughput Screening
14%
Lenvatinib
14%
Biochemistry, Genetics and Molecular Biology
Proteogenomics
100%
Drug Response
50%
Proteomics
25%
Tyrosine Kinase Inhibitor
25%
Transcriptomics
25%
Mammalian Target of Rapamycin
25%
High Throughput Screening
25%
Genomics
25%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cancer
100%
Neoplasm
14%
Biological Marker
14%
Drug Screening
14%
Mammalian Target of Rapamycin Inhibitor
14%
Temsirolimus
14%
Combination Drug
14%
Protein Tyrosine Kinase Inhibitor
14%
Lenvatinib
14%